LFMD · LifeMD Inc
United States · RS rating 12 · As of 2026-11-03
| Price | 2.18 USD |
|---|---|
| 1-day change | -5.6% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 22 / 13 / 15 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 4 / 34 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +510.0% |
| Sales growth Q/Q | -88.2% |
| Distance from 52-week high | +62.0% |
| Market cap (USD) | $214.9M |